Drug Shortage Report for ZITHROMAX

Last updated on 2023-01-17 History
Report ID 167977
Drug Identification Number 02212021
Brand name ZITHROMAX
Common or Proper name ZITHROMAX
Company Name PFIZER CANADA ULC
Market Status MARKETED
Active Ingredient(s) AZITHROMYCIN
Strength(s) 250MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size 1x6 blister
ATC code J01FA
ATC description MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2022-10-13
Estimated end date
Actual end date 2023-01-16
Shortage status Resolved
Updated date 2023-01-17
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 17300 TRANS-CANADA HIGHWAY
KIRKLAND, QUEBEC
CANADA H9J 2M5
Company contact information Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v14 2023-01-17 English Compare
v13 2023-01-16 French Compare
v12 2023-01-16 English Compare
v11 2022-11-10 French Compare
v10 2022-11-10 English Compare
v9 2022-10-14 English Compare
v8 2022-10-13 French Compare
v7 2022-10-13 English Compare
v6 2022-10-08 English Compare
v5 2022-09-08 French Compare
v4 2022-09-08 English Compare
v3 2022-09-04 English Compare
v2 2022-08-25 French Compare
v1 2022-08-25 English Compare

Showing 1 to 14 of 14